JASMINE JAMERSON: Open Payments
NPI 1013789148 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 22 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $685 · 2025 $513
Food & beverage: $411Education: $101
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $153 |
| Teva Pharmaceuticals USA, Inc. | 5 | $144 |
| ABBVIE INC. | 3 | $83 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Alkermes, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Corium, LLC | 1 | $12 |
Products named: CAPLYTA, VRAYLAR, Jornay PM, REXULTI, UZEDY, SPRAVATO, ARISTADA, AUSTEDO XR.
Industry payments across CO — which companies pay providers there.
